Contact us Address NCIRS, Kids Research, Sydney Children's Hospitals Network, Cnr Haweksbury Rd & Hainsworth St, Westmead Post: Locked Bag 4001, Westmead NSW 2145, Australia E: schn-ausvaxsafety@health.nsw.gov.au NCIRS is located in the Kids Research building, situated next door to The Children's Hospital at Westmead (refer to map). We are unable to provide medical advice to the general public via email. Please speak to your doctor to discuss your specific clinical situation. Your healthcare provider is advised to contact the appropriate immunisation specialist service in your state if additional clinical support is required. If you would like to report an adverse event following immunisation (AEFI), please visit the Australian Government Department of Health and Aged Care website to find out how you can report AEFIs in your state or territory. Please visit the Australian Government Department of Health and Aged Care website for additional information on COVID-19 vaccines, eligibility and where to be vaccinated. Last Name Telephone Your email address Message First Name CAPTCHA Where we are Contact Us By taxi If travelling by taxi, direct the driver to drop you at the front entrance of The Children’s Hospital at Westmead. By train The Children’s Hospital at Westmead is a short walking distance from Westmead Station (450 metres). If you require further information visit CityRail. By bus There are several bus routes to The Children’s Hospital at Westmead. For further information visit Sydney Buses. By car Limited paid public parking including disabled parking is available in the Children's Hospital Medical Centre / visitor’s car park. Contact Us News & events All news & events 08 November 2024 | News Enhanced National Immunisation Program vaccine safety data now available 23 October 2024 | News AusVaxSafety study affirms short-term safety profile of Moderna and Novavax COVID-19 vaccine priming doses 01 October 2024 | News AusVaxSafety marks a decade of progress in vaccine safety 12 September 2024 | News AusVaxSafety surveillance of 2024 seasonal flu vaccines concludes with no safety issues identified